PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Feb-2025 Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results AccessWire
12-Feb-2025 Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Platform Seaport Therapeutics
12-Feb-2025 OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod OKYO Pharma
12-Feb-2025 MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO MMS
12-Feb-2025 3d Cell Culture Market: Comprehensive Analysis and Forecast (2025–2035) Market Reports
12-Feb-2025 Travel Nurses, Inc. Named a Top Workplace by the Commercial Appeal for the Fourth Consecutive Year AccessWire
12-Feb-2025 Generic Drugs Market 2024-2035: Trends, Innovations, and Future Growth Market Business Insights
12-Feb-2025 Healthcare Analytics Market Size/Growth 2025-2035 Market Business Insights
12-Feb-2025 Single Cell Analysis (SCA) Market Size/Growth 2025-2035 Market Reports
12-Feb-2025 Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 AccessWire
12-Feb-2025 Candid Health Raises $52.5 Million Series C to Enhance GenAI Features, Expand Revenue Cycle Automation Platform to More Providers AccessWire
12-Feb-2025 Hearing Aids Market Size, Share, Trends, Demand Growth Analysis | 2025-2035 Vantage Market Research
12-Feb-2025 Pharmaceutical Water Market Insights on Innovations & Opportunities Cervicorn Consulting
12-Feb-2025 Cancer/Oncology Drugs Market Analysis (2024-2035): Trends, Innovations, and Future Projections Market Reports
12-Feb-2025 Cancer Biomarkers Market (2024-2035) - Comprehensive Analysis & Future Outlook Market Reports
12-Feb-2025 Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7% Market Business Insights
12-Feb-2025 Trading Update for the year ended 31 December 2024 AOTI, INC.
12-Feb-2025 BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in hidradenitis suppurativa (HS) UCB
12-Feb-2025 Aqilion carries out a rights issue of approximately SEK 26.8 million Aqilion
12-Feb-2025 Lundbeck’s potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA Lundbeck